Researchers continue to excited about Retatrutide , a innovative dual treatment showing remarkable outcomes in early trials for size management. It acts by modulating both hormones : GLP-1 and GIP, that , when engaged , help control hunger and boost energy expenditure . Initial observations suggest considerable body management and possible benefits